Event

Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026

Monday, January 12, 2026

Sidley Speakers

Torrey CopeMeenakshi DattaSally Wagner Partin

イベント詳細

日付Monday, January 12, 2026

11:30 a.m. - 2:30 p.m. PT

For questions, please contact sfevents@sidley.com.

Join members of Sidley's Global Life Sciences team for a lunchtime CLE-accredited program during the JPM Healthcare Conference discussing the latest regulatory trends impacting the next wave of development-stage transactions.

Led by Meena Datta, global co-leader of Sidley's Healthcare practice; Torrey Cope, partner in Sidley's Food Drug and Medical Device (FDMD) practice; and Sally Wagner Partin, partner in Sidley's M&A practice, this session provides keen insights on the considerations driving recent biotech dealmaking. 1 hour CLE credit available.